Article

Plasma miRNA-214 is a predictive candidate biomarker of progression speed in patients with ALS

2022-05-04

Abstract excerpt

<h4>ABSTRACT</h4> This study was designed to develop and validate a reliable biomarker to predict the progression speed reflecting immune function of amyotrophic lateral sclerosis (ALS). After establishing the induced microglia model (iMGs) derived from peripheral blood monocytes, comparative studies to find factors related to phagocytic differences between iMGs of patients with rapidly progressive ALS [ALS(R)-iM...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 39c92bb9-5032-5f9c-bc62-c1775e155fa0
DOI: 10.1101/2022.05.04.490596

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Plasma miRNA-214 is a predictive candidate biomarker of progression speed in patients with ALSDOI 10.1101/2022.05.04.490596Read

Defective phagocytic function of induced microglia-like cells is correlated with rapid progression of sporadic ALSSemantic proximity Read

Role of NCKAP1 in the Defective Phagocytic Function of Microglia-Like Cells Derived from Rapidly Progressing Sporadic ALSSemantic proximity Read

Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control studySemantic proximity Read

Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis.Semantic proximity Read

ALS monocyte-derived microglia reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progressionSemantic proximity Read

Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis: a longitudinal cohort studySemantic proximity Read

A monocyte gene expression signature in the early clinical course of Parkinson’s diseaseSemantic proximity Read

Human amyotrophic lateral sclerosis/motor neuron disease: The disease‐associated microglial pathway is upregulated while APOE genotype governs risk and survivalSemantic proximity Read

A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosisSemantic proximity Read

Circulating miRNA biomarkers for sporadic Amyotrophic Lateral Sclerosis: a systematic meta-analysis and empirical validationSemantic proximity Read

miRNA profiling as a complementary diagnostic tool for amyotrophic lateral sclerosisSemantic proximity Read

Investigation Genomic Landscapes, Molecular Mechanisms, and Extracellular Vesicles MiRNAs in Astrocyte and Oligodendrocyte Derived Amyotrophic Lateral SclerosisSemantic proximity Read